OTCMKTS:KNBWY

Kirin Q4 2025 Earnings Results & Report

Kirin logo
$19.61 -0.22 (-1.11%)
As of 01:44 PM Eastern

Kirin beat analyst expectations on both earnings and revenue in its Q4 2025 results, released February 13, 2026. The company reported EPS of $0.3614 versus the $0.30 consensus estimate, while revenue of $4.44 billion topped the $4.22 billion estimate by $214.36 million.

Earnings Announcement Details

Quarter
Q4 2025
Time
Before Market Opens

Kirin EPS Results

Actual EPS
$0.3614
Consensus EPS
$0.30
Beat/Miss
Beat by +$0.0614
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 7 quarters

Kirin Revenue Results

Actual Revenue
$4.44 billion
Expected Revenue
$4.22 billion
Beat/Miss
Beat by +$214.36 million
YoY Revenue Growth
N/A

Conference Call Resources

Kirin Q4 2025 Earnings FAQ

Kirin (OTCMKTS:KNBWY) reported earnings of $0.3614 per share for Q4 2025, beating the consensus estimate of $0.30. The report was announced on Friday, February 13, 2026.

Kirin reported revenue of $4.44 billion for Q4 2025, against a consensus estimate of $4.22 billion.

Kirin Earnings Headlines

A Bill Would Reprice America's Gold at Market Value
The US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,000 today, leaving a trillion-dollar gap on the books. A bill now moving through Congress would require the Treasury to reprice America's gold at true market value. Companion legislation would trigger the first full audit of US reserves in over 65 years.tc pixel
Kirin (KNBWY) Set to Announce Earnings on Tuesday
See More Kirin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kirin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kirin and other key companies, straight to your email.

About Kirin

Kirin (OTCMKTS:KNBWY) Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets.

The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.

Kirin is headquartered in Tokyo and serves customers across Japan and overseas, including markets in Asia-Pacific and other regions through its operating companies and businesses. Its portfolio spans consumer beverages as well as health-related products and medicines.

View Kirin Profile